Craft

Pelican Expression Technology

Stock Price

$12.8

2020-10-05

Market Capitalization

$437.3 M

2020-10-05

Revenue

$50.3 M

FY, 2019

Pelican Expression Technology Summary

Company Summary

Overview
Pelican Expression Technology™ (formerly Pfenex Expression Technology®) is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins. The Company has developed a high-quality protein production and bioanalytic technology platform approach that allows them to create biosimilars in a highly efficient manner.Pfenex's patented protein production platform, Pfenex Expression Technology, enables its ability to produce complex proteins relative to other systems. With advantages including quality, stability, solubility, and purity, Pfenex reduces production and development costs that enable the rapid delivery of protein products into clinical development and commercialization.
Type
Public
Status
Active
Founded
2009
HQ
San Diego, CA, US | view all locations
Website
https://pelicanexpression.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Diane Retallack

    Diane Retallack, SVP, Platform Technology and Innovation

    • Jeff Allen

      Jeff Allen, VP, Protein Sciences

      • Keith Haney

        Keith Haney, VP, Operations

        LocationsView all

        1 location detected

        • San Diego, CA HQ

          United States

          10790 Roselle St

        Pelican Expression Technology Financials

        Summary Financials

        Revenue (Q2, 2020)
        $781.0K
        Gross profit (Q2, 2020)
        $101.0K
        Net income (Q2, 2020)
        ($10.3M)
        Cash (Q2, 2020)
        $61.0M
        EBIT (Q2, 2020)
        ($10.3M)

        Footer menu